脑干剂量与头颈癌放疗患者报告的急性疲劳相关
本研究在124例接受根治性放疗的头颈癌患者中,于放疗前、放疗第6周和放疗后1个月前瞻性采集MFI-20疲劳评分,分析中枢神经系统结构剂量与疲劳评分的关联。结果显示脑干和延髓最大剂量与放疗第6周及放疗后1个月的MFI-20评分显著相关,而其他中枢神经系统结构剂量与评分无显著关联。
要点
- 脑干和延髓最大剂量与头颈癌放疗患者急性疲劳评分显著相关。
- 延髓最大剂量每增加1Gy,放疗第6周和放疗后1个月MFI-20总分较基线分别增加0.30和0.25。
- 脑干最大剂量每增加1Gy,放疗第6周和放疗后1个月MFI-20总分较基线分别增加0.30和0.25。
核心结论
- 脑干和延髓最大剂量与头颈癌根治性放疗患者急性疲劳风险显著增加相关。
研究设计与样本
- 前瞻性研究,纳入124例接受根治性放疗的头颈癌患者,在放疗前、放疗第6周和放疗后1个月采集MFI-20评分。
主要发现
- 控制基线评分后,脑干和延髓Dmax与放疗第6周和放疗后1个月MFI-20评分显著相关(p<0.05)。
- 延髓Dmax每增加1Gy,MFI-20总分较基线在放疗第6周增加0.30(p=0.026),放疗后1个月增加0.25(p=0.037)。
- 脑干Dmax每增加1Gy,MFI-20总分较基线在放疗第6周增加0.30(p=0.027),放疗后1个月增加0.25(p=0.037)。
- 其他中枢神经系统结构(小脑、后颅窝、垂体等)剂量与MFI-20评分无统计学显著关联。
临床怎么用
- 头颈癌放疗计划设计时,在满足靶区覆盖前提下应关注脑干和延髓最大剂量,以可能降低患者急性疲劳风险。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Radiation (RT) dose to the central nervous system (CNS) has been implicated as a contributor to treatment-related fatigue in head and neck cancer (HNC) patients undergoing radiation therapy (RT). This study evaluates the association of RT dose to CNS structures with patient-reported (PRO) fatigue scores in a population of HNC patients. MATERIALS AND METHODS: At pre-RT (baseline), 6th week of RT, and 1-month post-RT time points, Multidimensional Fatigue Inventory (MFI-20) scores were prospectively obtained from 124 patients undergoing definitive treatment for HNC. Medulla, pons, midbrain, total brainstem, cerebellum, posterior fossa, and pituitary dosimetry were evaluated using summary statistics and dose-volume histograms, and associations with MFI-20 scores were analyzed. RESULTS: Maximum dose (Dmax) to the brainstem and medulla was significantly associated with MFI-20 scores at 6th week of RT and 1-month post-RT time points, after controlling for baseline scores (p<0.05). Each 1Gy increase in medulla Dmax resulted in an increase in total MFI-20 score over baseline of 0.30 (p=0.026), and 0.25 (p=0.037), at the 6th week of RT and 1-month post-RT, respectively. Each 1Gy increase in brainstem Dmax resulted in an increase in total MFI-20 score over baseline of 0.30 (p=0.027), and 0.25 (p=0.037) at the 6th week of RT, 1-month post-RT, respectively. Statistically significant associations were not found between dosimetry for the other CNS structures and MFI-20 scores. CONCLUSIONS: In this analysis of PRO fatigue scores from a population of patients undergoing definitive RT for HNC, maximum dose to the brainstem and medulla was associated with a significantly increased risk of acute patient fatigue.
引用
- Ferris MJ, Zhong J, Switchenko JM, et al. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiother Oncol. 2017. PMID: 28826628. doi:10.1016/j.radonc.2017.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。